Company Performance Metrics
- Ronen Jaffe: Co-Founder
- Maysa Mustafa: CEO
Ceretrieve is a medical device company developing a medical device for treating ischemic stroke. They also developing an innovative neuro-thrombectomy system with integrated embolic protection features that will safely and efficiently extract blood clots from large vessels in the brain and restore blood flow following an ischemic stroke.
The
Company’s next-generation aspiration catheter will improve clinical outcomes by securely removing the entire clot in one pass with the catheter’s proprietary large-bore funnel and closure tip. CathTrap provides physicians with a safe, easy-to-use device to prevent distal embolization during thrombectomy procedures for better treatment efficiency and offers patients improved clinical outcomes.
Ceretrieve was founded in December 2016 and is headquartered in Misgav, Israel.
